CJC-1295 w/o DAC 5mg, Ipamorelin 5mg – 10mg

CJC-1295 (w/o DAC) 5mg / Ipamorelin Research Compound Blend

This combination of CJC-1295 (without DAC) and Ipamorelin is selected for laboratory investigation into growth hormone–associated signaling pathways and receptor-mediated endocrine communication mechanisms. Each peptide is commonly evaluated in controlled research environments examining hypothalamic–pituitary axis activity and downstream metabolic signaling processes.

Within structured scientific models, researchers explore pulsatile growth hormone pathway dynamics, receptor-specific modulation, and associated protein and lipid–related metabolic signaling frameworks. Investigation into circadian-related hormonal activity and broader neuroendocrine communication remains preliminary, model-specific, and highly dependent on experimental design and study conditions.

Research Applications

• Investigation of growth hormone–associated signaling pathways

• Evaluation of receptor-mediated endocrine communication

• Study of hypothalamic–pituitary axis regulatory mechanisms

• Analysis of protein and lipid–associated metabolic signaling

• Inclusion in multi-compound endocrine research models

For research use only. Not for human consumption.
This product is not approved by the U.S. Food and Drug Administration and is supplied strictly for laboratory, educational, and research purposes.